Corporate Governance

Overview | Management | Guidelines | Conduct

Accentia BioPharmaceuticals is committed to a high standard of business ethics. Ethical, transparent and lawful conduct of business operation is a shared value of our Board of Directors, management and employees. Critical to our success as we pursue our financial objectives and mindful of the patients we serve, honesty and integrity is never compromised. Consistent with these principles, Accentia has developed Corporate Governance Guidelines and a Code of Conduct and Ethics. Committee Charters Compensation Committee Audit Committee Governance Committee Governance Documents Accentia Bylaws

Board of Directors

• Francis E. O'Donnell, Jr., M.D., Chairman
• Steven R. Arikian, M.D.
• Alan M. Pearce
• John P. Dubinsky, M.D.
• David M. Schubert
• Todd D. Thomason
• Edmund C. King
• William S. Poole

Management

Francis E. O'Donnell, Jr., M.D.
Chairman and CEO

Steven R. Arikian, M.D.
President, Chief Operating Officer of Product Development and Market Services

Alan M. Pearce
Chief Financial Officer

Samuel S. Duffey, Esq.
General Counsel